# Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer

> **NCT07021846** · NA · RECRUITING · sponsor: **Fondazione Policlinico Universitario Campus Bio-Medico** · enrollment: 132 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** hypofractionated radiotherapy with tumor bed boost

## Key facts

- **NCT ID:** NCT07021846
- **Lead sponsor:** Fondazione Policlinico Universitario Campus Bio-Medico
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-12
- **Primary completion:** 2026-03
- **Final completion:** 2030-03
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07021846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07021846, "Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07021846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*